Although probiotics have been reported to reduce the gastric inflammatory response to Helicobacter pylori infection, little information is available regarding the molecular mechanisms behind this reduction. This study investigates the role of conjugated linoleic acids (CLA) produced by probiotics in interactions of IkB kinase (IKK) and heat shock protein 90 (Hsp90) to activate the nuclear factor-kappaB (NF-kB) signaling pathway in human gastric epithelial cells infected with H. pylori. Conditioned medium (CM) containing Lactobacillus acidophilus-producing CLA significantly inhibited the activated NF-kB signals and the upregulated expression of interleukin-8 (IL-8) in MKN-45 cells infected with H. pylori. Pretreatment with CM with CLA attenuated the increased IKK activity induced by H. pylori. Transfection of siRNA for IKK-b dramatically reduced H. pylori-induced IkBa phosphorylation, but siRNA for IKK-a had little effect on IkBa phosphorylation, although the siRNA for IKK-a significantly decreased IL-8 production. Furthermore, Hsp90 was associated with IKK-a and IKK-g in H. pylori-infected cells, and CM with CLA dissociated the complex between Hsp90 and IKK-g. These results suggest that CLA produced by probiotics has anti-inflammatory activity in gastric epithelial cells infected with H. pylori via dissociation of the IKK-g and Hsp90 complex.
Helicobacter pylori is a pathogen that has an important role in the pathogenesis of chronic gastritis, peptic ulcers, gastric adenocarcinoma, and gastric mucosa-associated lymphoid tissue lymphoma.
1,2 Persistent colonization of H. pylori in the human stomach results in the release of chemoattractants, such as interleukin-8 (IL-8). The released IL-8 induces the infiltration of neutrophils into the gastric mucosa, leading to chronic gastritis.
Nuclear factor-kappaB (NF-kB) is an important transcriptional factor that controls various biological processes, such as inflammation, cell survival or death, and the cell cycle. NF-kB dimers are stored in the cytoplasm in an inactive state by inhibitory proteins called IkBs. IkB kinase (IKK) is known to directly phosphorylate IkB, which then undergoes ubiquitin-mediated proteolysis, thereby releasing NF-kB dimers to translocate to the nucleus. The IKK complex contains three subunits: the catalytic subunits, IKK-a and IKK-b, and a regulatory subunit, IKK-g (also known as NEMO, NF-kB essential modulator). [3] [4] [5] [6] While IKK-a and IKK-b are essential for IkB phosphorylation, IKK-g forms a tetrameric scaffold that can assemble two kinase dimers to facilitate trans-autophosphorylation. 7, 8 Recently, heat shock protein 90 (Hsp90) has been found to associate stoichiometrically with the IKK complex, which may contribute to the stabilization, activation and/or shuttling of IKKs to the plasma membrane, since Hsp90 regulates the stability and function of a unique complement of signaling molecules. [9] [10] [11] [12] Considering that the Hsp90-CDC37 chaperone complex has been implicated in the maturation of kinases and the IKKa/b/g complex, and that the pharmacological inhibition of Hsp90-CDC37 by geldanamycin inhibits the TNF-amediated activation of NF-kB, 10, 13 signal transduction to NF-kB activation by stimulators such as TNF-a includes Hsp90 molecules. Several strains of bacteria that are considered to have probiotic effects, including Lactobacilli and Bifidobacteria species, are capable of converting linoleic acid to conjugated linoleic acid (CLA). CLA is a collective term used to describe a set of 28 distinct positional and geometric isomers of linoleic acid 14 and is most commonly found at positions cis-9, trans-11 (c9,t11) and trans-10, cis-12 (t10,c12), both of which possess biological activity. 15 CLA has been shown to exert numerous health benefits, including antiatherogenic, anti-diabetic, anti-inflammatory, and anticarcinogenic properties. 16 Although probiotics have been shown to reduce the gastric inflammatory response to H. pylori infection, 17 little information is available regarding the molecular mechanism for Lactobacilli-induced attenuation of gastric inflammation. This study asked whether CLA produced by Lactobacillus acidophilus may affect the NF-kB signal transduction pathway to upregulate the IL-8 inflammatory response to CagA þ H. pylori. CLA produced by L. acidophilus is shown herein to reduce NF-kB activity and IL-8 expression through dissociation of the IKK and Hsp90 complex in human gastric epithelial cells infected with H. pylori.
MATERIALS AND METHODS
Cell Culture, H. Pylori Strain, and Assessment of CLA Produced by L. Acidophilus The MKN-45 gastric epithelial cell line was maintained at 371C in 5% CO 2 in RPMI-1640 medium, supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY, USA) and antibiotics (100 U/ml of penicillin and 100 mg/ml of streptomycin). 18 CagA þ H. pylori strain 60190 (ATCC 49503, vacA s1a/m1) was maintained under microaerophilic conditions in Brucella broth that was supplemented with 5% horse serum. 19 Bacteria were centrifuged at 3500 Â g for 5 min at 41C and washed with phosphate-buffered saline (PBS). The bacterial concentrations were estimated using an optical density at 560 nm (OD560) of 0.1, as 4 Â 10 7 CFU/ml H. pylori. MKN-45 cells in six-well plates were pretreated with conditioned medium (CM) containing CLA 1 h prior to the addition of H. pylori at a multiplicity of infection of 100. For the preparation of the CM, L. acidophilus (ATCC 832, approximately 1 Â 10 7 CFU/100 ml of culture medium) was incubated for 18 h with 0.5 g/l of linoleic acid (Sigma Chemical Co., St Louis, MO, USA) in RPMI-1640, in which the bacteria were grown to the stationary phase. Live bacteria were removed by filtration through a 0.2 mm syringe filter, and the CM was placed onto the MKN-45 cells. Serial 100-fold dilutions of CM were plated on brain-heart infusion medium to ensure the absence of viable bacteria.
Amounts of CLA were measured as described previously. 20, 21 L. acidophilus was incubated for 18 h at 371C in 10 ml of RPMI-1640 or Mann-Rogosa-Sharpe broth in the presence or absence of 0.5 g/l of linoleic acid suspended in 0.05% Tween-80. Samples were centrifuged at 3500 Â g for 15 min, from which process supernatants were obtained. To extract lipids from the supernatants immediately, 24 ml of a 2:1 chloroform:methanol solution and 8 ml of 0.88% NaCl were mixed with 2 ml of medium. Ten milliliters of the lower layer of the mixture were dried under nitrogen at 401C and resuspended in hexane. Fatty acid methyl esters were produced by incubating the samples with 40 ml methyl acetate and 80 ml sodium methoxide for 15 min at 501C. Methylated fatty acids were subjected to gas chromatography on a Varian 3600 GC using a SP2560 column (Supelco). Integration and quantitation were performed using the Class-VP Chromatography Data System (version 4.2, Shimadzu Scientific Instruments). Purified c9,t11-and t10,c12-CLA isomers were obtained from Matreya (State College, PA, USA).
In some experiments, intestinal epithelial cells were pretreated with an NEMO-binding domain (NBD) peptide (200 mM, Peptron, Daejeon, Korea) for 1 h before addition of H. pylori. An NBD peptide can block the association of NEMO with the IKK complex and inhibit NF-kB activation. 22, 23 Sequences of the wild-type and mutant peptides are drqikiwfqnrrmkwkkTALDWSWLQTE (wild) and drqikiwfqnrrmkwkkTALDASALQTE (mutant). Positions of the W-A mutations are underlined. 22 
Transfection and Reporter Assays
The reporter plasmids, pIL8-luciferase, p2x NF-kB-luciferase, and pb-actin-and pRSV-b-galactosidase-luciferase transcriptional reporters, were provided by Dr Kagnoff of the University of California, San Diego. 24 In the reporter analysis, cells in six-well dishes were transfected with 1.5 mg of plasmid DNA using Lipofectamine Plus reagents (Invitrogen, Carlsbad, CA, USA), as described previously. 25 The transfected cells were incubated for 48 h at 371C in a 5% CO 2 incubator. Cells were then harvested, and whole cell lysates were prepared as described previously. 25 Luciferase activity was determined in accordance with the manufacturer's instruction (Tropix Inc., Bedford, MA, USA) and luminescence was quantitated for 10 s using a luminometer (MicroLumat Plus, Berthold GmbH & Co. KG, Bad Wildbad, Germany). Luciferase activity was determined and normalized relative to b-galactosidase expression in accordance with the manufacturer's instruction (Tropix Inc.). Briefly, b-galactosidase activity was determined using the chemiluminescent substrate AMPGD (3-(4- 
Inc.) as described before. 18, 20 Luminescence was induced by the addition of 50 ml 0.2 N NaOH containing 10% Emerald enhancer (Tropix Inc.) and quantitated for 10 s in a luminometer. Increased activity from pIL-8, p2x NF-kB, and pb-actin promoters was calculated by comparing ratios of luciferase to b-galactosidase activities in the cells co-transfected with pIL8-luciferase and pRSV-b-galactosidase, p2x NF-kBluciferase and pRSV-b-galactosidase, or pb-actin-luciferase and pRSV-b-galactosidase, respectively. Non-transfected cells were used as a background control.
RNA oligonucleotides for silencing IKK-a (5 0 -GCA GGCU CUUUCAGGGACA-3 0 ), IKK-b (5 0 -GUGAAGAGGUGGUGG UGAGC-3 0 ), and the nonsilencing control (5 0 -UUCUCCGAA CGUGUCACGU-3 0 ) with two thymidine residues (dTdT) at the 3 0 end were synthesized together with their corresponding antisense RNAs and then annealed (QIAGEN, Hilden, Germany), as described previously. 27 For knockdown of human hsp90 mRNA, siRNA for Hsp90 purchased the predesigned siRNA (siGENOME SMARTpool reagent) from Dharmacon (Lafayette, CO, USA).
Quantitative RT-PCR, Real-Time PCR, and EnzymeLinked Immunosorbent Assay Total cellular RNA from MKN-45 cells was extracted from the cells using an acid guanidinium thiocyanate-phenolchloroform method (Trizol; GIBCO BRL, Gaithersburg, MD, USA). Quantitative RT-PCR for IL-8 and b-actin mRNA was performed using standard internal RNA, and real-time PCR was carried out using an ABI PRISM 7700 Sequence Detection System (Perkin-Elmer Applied Systems, Foster City, CA, USA) and SYBR green fluorescent dye, as described previously. 19 Probes, reagents, and TaqMan cytokine gene expression plates were used as recommended by the manufacturer (Applied Biosystems, Foster City, CA, USA). IL-8 in culture supernatants was assayed by enzyme-linked immunosorbent assay (ELISA). Prior to measuring the IL-8 protein, the supernatants were filtered through a 0.22-mm filter to remove any contaminants. Human IL-8 was quantitated using a Quantikine immunoassay kit (R&D Systems, Minneapolis, MN, USA). To measure levels of phospho-IkBa, an IkBa ELISA kit was used (Active Motif, Carlsbad, CA, USA).
Electrophoretic Mobility Shift Assay
Cells were harvested and nuclear extracts were prepared as described previously. 18 Concentrations of protein in the extracts were determined by the Bradford assay (Bio-Rad, Hercules, CA, USA). Electrophoretic mobility shift assays (EMSA) were performed according to the manufacturer's instructions (Promega, Madison, WI, USA). In brief, 5 mg of nuclear extracts were incubated for 30 min at room temperature with a g 32 P-labeled oligonucleotide probe corresponding to a consensus NF-kB-binding site. After incubation, both bound and free DNAs were resolved on 5% native polyacrylamide gels, as described previously. 18 Supershift assays were used to identify the specific members of the NF-kB family activated by H. pylori infection. EMSA was performed as described above, except that rabbit antibodies (1 mg/reaction) against NF-kB proteins p50, p52, p65, c-Rel, and Rel B (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added during the binding reaction period. 28 Immunoblots Cells were washed with ice-cold PBS and lysed in a 0.5 ml/ well lysis buffer (150 mM NaCl, 20 mM Tris pH 7.5, 0.1% Triton X-100, 1 mM PMSF, and 10 mg/ml aprotinin). Fifteen to fifty micrograms protein per lane was size-fractionated on a 6% polyacrylamide minigel (Mini-PROTEIN II; Bio-Rad) and electrophoretically transferred to a nitrocellulose membrane (0.1-mm pore size). Specific proteins were detected using mouse anti-human IkBa (Santa Cruz Biotechnology), IKK-a, IKK-b, IKK-g, Hsp90, and actin (Cell Signaling Technology, Beverly, MA, USA) as primary antibodies, and peroxidase-conjugated anti-mouse IgG (Transduction Laboratories, Lexington, KY, USA) as a secondary antibody. Specifically bound peroxidase was detected by enhanced chemiluminescence (ECL system; Amersham Life Sciences, Buckinghamshire, England) and exposure to X-ray film.
Immunoprecipitation
For the immunoprecipitation assay, the cells were collected in lysis buffer (50 mM HEPES at pH 7.6, 150 mM NaCl, 0.1% NP-40, 5 mM EDTA, 0.5 mM phenylmethyl sulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin) after treatments as described in the figure legends. The lysates were mixed and precipitated with the relevant antibody and protein G-sepharose beads by incubation at 41C for overnight. Anti-HA and anti-flag antibodies were purchased from Santa Cruz Biotechnology and Sigma, respectively. HAtagged IKK-a, IKK-b, and IKK-g constructs were kindly supplied by Dr Gang Min Hur at Chungnam National University, Korea. 29 For the detection of the modified IKK-g protein, MKN-45 cells were lysed in a lysis buffer (20 mM Tris at pH 7.6, 0.5% NP-40, 150 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM DTT, 0.5 mM PMSF, 20 mM b-glycerol phosphate, 1 mM sodium vanadate, 1 mg/ml leupeptin, and 10 mM N-ethylmaleimide) and lysates were incubated with anti-IKK-g antibody and protein G-sepharose. All immunoprecipitates were washed four times with lysis buffer, boiled in sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer, and resolved on an 8% polyacrylamide gel. 30 In Vitro Kinase Assay IKK activity on IkBa phosphorylation was determined by using an immunocomplex kinase assay, as described previously. 31 Cells were lysed in Triton lysis buffer containing protease and phosphatase inhibitors and then cleared by centrifugation at 14 000 r.p.m. for 10 min. Three hundred micrograms of whole cell extract was immunoprecipitated with anti-IKK-g/protein-A beads, and the kinase reaction was performed by incubating 25 ml of kinase buffer containing 20 mmol/l of HEPES (pH 7.7), 10 mmol/l of MgCl 2 , 5 mmol/l of dithiothreitol, 50 mmol/l of ATP, and 5 mCi of [g- 
Statistical Analyses
Wilcoxon's rank sum test was used for the statistical analyses. A P-value less than 0.05 was considered statistically significant.
RESULTS

L. acidophilus
Produces CLA in Broth Culture Supernatants Gas chromatography was used to measure the amounts of c9,t11-and t10,c12-CLA produced by L. acidophilus. The amounts of c9,t11-and t10,c12-CLA produced by L. acidophilus were 927.6 ± 51.8 mg/mg protein and 736.2 ± 32.6 mg/mg protein, respectively (mean ± s.e.m., n ¼ 5). However, CM (0-40%) obtained from the incubation with L. acidophilus in the absence of linoleic acid did not show significant changes of the IL-8 releases induced by H. pylori. In this experiment, significant inhibitions of IL-8 release by CM without CLA were found in more than 60% of treated concentration, but their inhibitions were lower compared with those by CM from L. acidophilus with CLA.
To confirm the decrease of IL-8 release by CM containing L. acidophilus-producing CLA, the numbers of IL-8 mRNA transcripts were measured by real-time PCR and quantitative RT-PCR using an internal RNA standard. The result of this experiment showed that the upregulated expression of IL-8 mRNA was significantly reduced by the addition of CLAcontaining CM (Figure 2a) . However, the addition of CM Since c9,t11 and t10,c12 are known to be the most commonly found among total CLA, 15 we performed an experiment to confirm whether pure c9,t11-and t10,c12-CLA isomers could downregulate IL-8 expression in H. pylori-infected gastric epithelial cells. Pretreatment with t10,c12-CLA significantly attenuated IL-8 secretion in MKN-45 cells infected with H. pylori (Po0.01). However, c9,t11-CLA had little decrease of IL-8 secretion (P ¼ 0.082) (Figure 3) . Furthermore, inhibition by pretreatment with CM obtained from the incubation with L. acidophilus in the presence of linoleic acid was higher than that by pretreatment with pure c9,t11-and t10,c12-CLA isomers (Po0.05). The IL-8 secretion by pretreatment with a mixture of c9,t11-and t10,c12-CLA isomers (20 mM each) did not show a synergistic effect (data not shown). Pretreatment with t10,c12-CLA (20 mM) also downregulated the increased activities of NF-kB and IKK in MKN-45 cells infected with H. pylori, measured reporter gene assay (H. pylori, 3.2 ± 0.4; H. pylori þ t10,c12, 1.9 ± 0.3; H. pylori þ c9,t11, 2.9 ± 0.3; mean fold induction ± s.e.m. of NF-kB luciferase activity relative to untreated control, n ¼ 3; H. pylori, 3.9±0.3; H. pylori þ t10,c12, 2.3±0.3; H. pylori þ c9,t11, 3.5 ± 0.4; mean fold induction ± s.e.m. of IKK-b kinase activity relative to untreated controls, n ¼ 3).
The transcription factor NF-kB is one component of a signaling pathway, which regulates IL-8 expression induced by H. pylori infection. 32 Consistent with this, infection with H. pylori increased NF-kB DNA binding, as shown by EMSA (Figure 4a) , in which increased level of NF-kB was first detected 10 min after infection and increased continuously until the end of the experiment (1 h post-infection) . Concurrently, degradation of IkBa was observed in H. pylori-infected cells. It was, therefore, asked whether CLA could prevent H. pyloriinduced NF-kB transcriptional activity in MKN-45 cells. As shown in Figure 4b (Figure 4c) . A supershift assay was performed to identify the specific NF-kB subunits that comprise the NF-kB signal detected by EMSAs in H. pylori-infected cells. Specific antibodies to p50, p52, p65, c-Rel, and Rel B were used for these experiments. Supershift studies demonstrated that antibodies to p65 and p50 shifted the NF-kB signals significantly. In contrast, anti-p52, anti-c-Rel or anti-Rel B antibodies did not shift the NF-kB signal (Figure 4d ). These results suggest that NF-kB activation by H. pylori infection is mediated predominantly by heterodimers of p65/p50.
To confirm the inhibition of NF-kB activation and IL-8 expression by CM containing CLA, luciferase assays for NFkB and IL-8 reporter genes were performed. Figure 5 shows that the activation of IL-8 and NF-kB transcriptional reporters was significantly inhibited in H. pylori-infected MKN-45 cells when pretreated with CM containing CLA. However, CM obtained from the incubation with L. acidophilus in the absence of linoleic acid did not show significant inhibition of the enhanced activities of IL-8 and NF-kB transcriptional reporters. These results indicate that the pretreatment with CM containing L. acidophilus-producing CLA significantly inhibits gastric epithelial inflammatory signals, such as NF-kB activation and IL-8 expression, induced by H. pylori infection.
H. Pylori Induces IKK Activation in MKN-45 Gastric
Epithelial Cells, and Culture Supernatants Containing CLA Produced by L. Acidophilus Inhibit the Activated IKK Signals Major pathways for NF-kB activation involve the activation of IKK, which is followed by IkB degradation. 3 Infection of MKN45 cells with H. pylori increased signals of phosphorylated IKK-a/b, which were first activated within 10 min of infection and reached their maximum after 60-120 min (Figure 6a ). We next asked whether activated IKK signals might be associated with the NF-kB activation and IL-8 ; mean number of mRNA transcripts±s.d. per mg RNA in 8 h after infection, n ¼ 5). In this experiment, the level of b-actin mRNA in each group showed relatively constant (B5 Â 10 6 mRNA transcripts/mg RNA). Since IKK-a and IKK-b are reported to be essential for IkBa phosphorylation and NF-kB activation, 4 it was necessary to determine which subunit of IKK is involved in IkBa phosphorylation when MKN-45 gastric epithelial cells were infected with H. pylori. As shown in Figure 7a , siRNA for 
IKK-b dramatically reduced H. pylori-induced
IkBa phosphorylation. In contrast, siRNA for IKK-a had little effect on IkBa phosphorylation, although the siRNA for IKK-a significantly decreased IL-8 production induced by H. pylori infection (Figure 7b ).
To determine the effects of CM on IKK activity, an in vitro kinase assay for IKK was performed. As shown in Figure 8a , the infection of MKN-45 cells with H. pylori induced a strong increase of IKK activity, and pretreatment with CM containing CLA significantly reduced H. pylori-induced IKK activity. To quantify the inhibition of IKK activity, HTScan IKK-b kinase assay was performed. Pretreatment with CM containing CLA significantly prevented IKK-b activity by B70% (Po0.01), while pretreatment with CM obtained from the incubation with L. acidophilus in the absence of linoleic acid had no significant effect (Figure 8b ). In this system, heat-killed H. pylori slightly increased IL-8 production in MKN-45 gastric epithelial cells (control, 127.7 ± 33.2; heat-killed H. pylori, 343.3±52.9; live H. pylori, 1794.0± 174.4; n ¼ 3, mean±s.e.m.). However, an experiment for IKK activation stimulated with heat-killed H. pylori showed that heat-killed H. pylori could not significantly activate IKK-b in MKN-45 gastric epithelial cells (live H. pylori, 3.3 ± 0.5; heat-killed H. pylori, 1.1 ± 0.3; n ¼ 5, mean fold induction for control ± s.e.m.).
To confirm the hypothesis of the Hsp90-IKK-NF-kB mechanism, levels of phospho-IkBa were measured. Since detection of phospho-IkBa is difficult because of the short half-life of phospho-IkBa, we used a commercial IkBa ELISA kit. The results showed that H. pylori increased the levels of phospho-IkBa in MKN-45 cells. In contrast, CLA-containing CM (20%) significantly reduced the levels of phospho-IkBa (Figure 8c ).
Hsp90 is Associated With IKK Proteins in MKN-45 Gastric
Epithelial Cells H. pylori is known to induce the phosphorylation of Hsp90 in gastric epithelial cells. 33 In addition, Hsp90 is directly associated with the kinase domains of IKK-a and IKK-b, and they contribute to the stabilization, activation, and/or translocation of IKK. 9, 10 On the basis of these results, it was asked whether Hsp90 might play a role in regulating the H. pylori-induced IKK activation in MKN-45 cells. First, the interactions of Hsp90 with IKK proteins in MKN-45 cells were examined when each protein of IKK-a, IKK-b, and IKKg was overexpressed in the cells. Interestingly, this experiment showed that IKK-b was unable to interact with Hsp90 ( Figure 9 ), indicating that the interaction of IKK-b and Hsp90 is presumably indirect in MKN-45 cells. In contrast, IKK-a and IKK-g strongly interacted with Hsp90 in each co-immunoprecipitation assay (Figure 9 ).
To determine whether Hsp90 is associated with expression of IL-8 gene, experiments of transfection with Hsp90 siRNA were performed. As shown in Figure 10a Figure 11a , the interaction between IKK-g and Hsp90 was reduced after 30 min of treatment with CM. In this experimental system, upregulated expression of IL-8 mRNA was significantly reduced by the addition of CLA-containing CM, using real-time PCR (Figure 2a) . However, the addition of CM obtained from the incubation with L. acidophilus in the absence of linoleic acid did not show significant changes of the interaction between IKK-g and Hsp90 (Figure 11b ).
DISCUSSION
This report examined the impact of CLA produced by L. acidophilus on the Hsp90-IKK complex of H. pyloriinfected gastric epithelial cells. CLA significantly decreases IKK activity by dissociation of the complex composed of IKK-g and Hsp90. This phenomenon is then associated with both the suppression of IkB phosphorylation and NF-kB activation, which finally results in the inhibition of IL-8 expression in gastric epithelial cells infected with H. pylori.
Lactobacillus species are commensal in the human alimentary tract, and their concentrations in the normal stomach vary between 0 and 10 3 /ml. As acid-resistant organisms, they persist in the stomach longer than other bacteria: dietary strains of bifidobacteria and Lactobacilli survive in high proportions (480%) in the gastric environment for periods of 2 h. 34 Specific strains of Lactobacillus exert in vitro bactericidal effects against H. pylori through the release of bacteriocins or the production of organic acids and/or the inhibition of its adhesion to epithelial cells. 17 In addition, some strains of Lactobacillus are reported to reduce proinflammatory chemokine expression during H. pylori infection. 35, 36 However, there exists little evidence regarding the molecular mechanism of Lactobacilli-induced suppression of inflammatory responses to H. pylori infection. Therefore, the findings of this study, including that CLA can suppress IL-8 expression and NF-kB activation in gastric epithelial cells infected with H. pylori through dissociation of the IKK-g-Hsp90 complex, support a new mechanism of probiotic action against inflammatory response to infection with H. pylori.
Activated IKK induces IkB phosphorylation, which is followed by NF-kB activation. 3 An experiment described in this study showed that treatment with CM containing CLA blocked H. pylori-induced IKK activity and decreased IL-8 expression. These results suggest that CLA affects an IKK site in the signaling pathway of gastric inflammation induced by H. pylori infection. In the previous study, we have demonstrated that IKK-b may play a more important role in H. pylori-induced IkBa phosphorylation compared with IKK-a. In addition, IKK-a and IKK-g strongly interacted with Hsp90 in MKN-45 gastric epithelial cells. Hsp90 is known to play an important role in signaling transduction networks and serves a critical function both in facilitating the biosynthesis of components of the IKK complex and in maintaining the mature forms of the kinase complex in a conformation that allows for its eventual biochemical function and stability. 9, 10 Along this line of reasoning, inhibition of Hsp90 significantly downregulates the increased IKK activity and IL-8 expression in H. pylori-infected MKN-45 cells, suggesting an important role for Hsp90 in the signaling mechanism of inflammatory responses to H. pylori infection. Furthermore, Hsp90 seems to be directly associated with IKK-g in gastric epithelial cells infected with H. pylori. Experiments from this study supported this hypothesis; the interaction between IKK-g and Hsp90 was reduced after treatment with CM containing CLA. Concurrently, the interruption of the association between IKK-g and Hsp90 by CLA resulted in the decrease of IL-8 mRNA expression. These results suggest that CLA produced by L. acidophilus may induce the dissociation of the complex between Hsp90 and IKK-g molecules in MKN-45 gastric epithelial cells infected with H. pylori.
Hsp90 can regulate Nod1, which induces inflammatory responses to bacterial infection using the components of the bacterial cell well 37, 38 and H. pylori also induces the phosphorylation of Hsp90 in gastric epithelial cells. 33 Therefore, it is possible that pretreatment with CLA-containing CM may affect the expression of Hsp90 molecules in H. pylori-infected gastric epithelial cells. Further study is needed to clarify this possibility.
H. pylori can activate MAPK signaling pathway to IL-8 production in gastric epithelial cells 39 and MAPK may be associated with NF-kB activation, suggesting an association between MAPK and IKK activation in H. pylori-infected gastric epithelial cells. Considering that CLA from L. acidophilus do not completely inhibit H. pylori-induced IL-8 production and NF-kB activation in the present study, there may be other pathways that sustain the ability of H. pylori to induce proinflammatory cytokine production, including MAPK and AP-1 pathway. In addition, there is a possibility that CLA may block translocation of NF-kB into the nucleus or that it may exert effects on ubiquitination in intestinal epithelial cells, indicating that further study is needed to clarify other contributing factors to account for the CLAinduced decrease of IL-8 expression in gastric epithelial cells infected with H. pylori.
Several clinical trials have shown that probiotics generally do not eradicate H. pylori, although they decrease the density of colonization, thereby maintaining lower levels of H. pylori in the stomach. 40, 41 On the other hand, the antioxidant and anti-inflammatory properties exerted by probiotics may stabilize the gastric barrier function and decrease mucosal inflammation. 17 As suggested by the 2000-Maastricht Consensus Conference on H. pylori, probiotic microorganisms may be used as a possible tool for the management of H. pylori infection and its associated gastric inflammation. 42 The findings of this study provide evidence that CLA produced by probiotics can attenuate gastric inflammatory responses associated with H. pylori infection.
There are numerous CLA isomers present in CM that may have been obtained from the incubation of L. acidophilus in the presence of linoleic acid. However, the present study measured only two isomers of CLA, c9,t11 and t10,c12, because these isomers are known to be most commonly found among total CLA. 15 It was asked whether pure isomers of CLA have inhibitory effects on IL-8 expression in H. pyloriinfected MKN-45 cells. Pretreatment with pure t10,c12-CLA isomer significantly attenuated IL-8 secretion in MKN-45 cells infected with H. pylori. In contrast, c9,t11-CLA showed a tendency of decreasing IL-8 secretion but this inhibition had no significant value (P ¼ 0.082), suggesting that different isomers of CLA exert differential effects on gastric epithelial cells infected with H. pylori. In addition, inhibition by pretreatment with CM containing L. acidophilus-producing CLA was significantly higher than that by pretreatment with pure c9,t11-and t10,c12-CLA isomers. These results also indicate that other components in CM obtained from L. acidophilus in the presence of linoleic acid may contribute to inhibiting inflammatory responses to H. pylori infection. Therefore, further study is needed to clarify the biochemical effects on H. pylori infection of CLA isomers or other components that may have been present in the CM.
In summary, this study has demonstrated that CLA produced by L. acidophilus has anti-inflammatory activity in gastric epithelial cells infected with H. pylori through the dissociation of IKK-g and Hsp90 complex. This CLA action is novel in the inhibition of the inflammatory responses to H. pylori infection, suggesting that CLA produced by probiotics may play a role in the host defense system.
